CAIR LGL
CAIR LGL designs, manufactures, and distributes single-use sterile medical devices for infusion, chemotherapy, enteral nutrition, and suction-ventilation, selling directly to hospitals and through wholly-owned subsidiaries in Belgium, Spain, Italy, and Singapore.
- Company typePrivate
- Founded1987
- HeadquartersLissieu, France
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What CAIR LGL does
CAIR LGL is a French medical device manufacturer founded in 1987 by Georges Gaston Lopez and his son Georges Antoine Lopez. The company designs, develops, manufactures, sterilizes, and commercializes single-use sterile medical devices for hospitals and healthcare facilities, organized across four therapeutic verticals: infusion (anchored by the proprietary Neutraclear™ bidirectional needleless injection valve, SPYDER multi-way extension lines in 2 to 6-way configurations, stopcocks, manifolds, and the DOSICAIR flow regulator), chemotherapy (the CHEMO-CAIR line covering dose preparation, bag preparation, administration sets, and rinsing sets for cytotoxic drug handling), enteral nutrition (the NUTRICAIR™ Enteral line with ENFit™ standardized connectors for feeding tubes, syringes, and hydration tubing), and suction-ventilation (including Salem-type naso-gastric tubes, mucus extractors, and vacuum control systems). The operating model is vertically integrated and B2B: products are sold through direct institutional sales from the Lissieu headquarters to hospitals and through wholly-owned subsidiaries in Belgium (Cair Belgium SRL, Liège), Spain (Laboratorios CAIR España S.L.U, Madrid), and Italy (CAIR ITALIA, Teolo), with a commercial office in Singapore supporting international reach. Production is conducted in-house at two French sites (Lissieu and Saint Laurent de Chamousset in the Rhône department) and a site near Sousse, Tunisia, with a logistics facility in Arnas, France. The company carries ISO 13485:2016, ISO 11135:2014, and CE2797 markings under G-MED certification, and is a member of French Healthcare and SNITEM. CAIR LGL is a privately held Société Anonyme with a registered capital of €11,116,980 and reported headcount of 251-500 employees; no revenue figures, funding rounds, or external ownership stakes are disclosed in the available data.
CAIR LGL firmographics
Firmographics- Name
- CAIR LGL
- Legal name
- Cair LGL, Société Anonyme
- Website
- https://cairlgl.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- CAIR LGL designs, manufactures, and distributes single-use sterile medical devices for infusion, chemotherapy, enteral nutrition, and suction-ventilation, selling directly to hospitals and through wholly-owned subsidiaries in Belgium, Spain, Italy, and Singapore.
- Ownership category
- akta.pro rank
CAIR LGL industry classification
Industry- Product category
- Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Infusion Sets, Catheters & Pump Consumables (HLAHAIAH)
- akta.pro secondary industries
- Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)
Keywords
Where CAIR LGL is headquartered
LocationHeadquarters
- HQ city
- Lissieu
- HQ country
- France
- HQ region
- Europe
Offices8 records
Markets served
CAIR LGL business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Single-use sterile medical device sales: CAIR LGL generates revenue through the manufacture and sale of single-use sterile medical devices. Products are sold as consumable medical supplies to healthcare facilities, hospitals, and healthcare professionals across infusion, chemotherapy, nutrition, and suction-ventilation applications. Devices are sold through direct sales to institutions and via subsidiary distribution networks in European markets.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels1 record
CAIR LGL product offering
Product offeringCore offering
CAIR LGL designs, develops, manufactures, sterilizes, and distributes single-use sterile medical devices for hospitals and healthcare facilities. Its portfolio spans four therapeutic areas: infusion (needleless valves, extension lines, flow regulators, stopcocks), chemotherapy (CHEMO-CAIR dose preparation, bag preparation, and administration sets), nutrition (NUTRICAIR enteral feeding with ENFit connectors), and suction-ventilation (gastric suction probes, mucus extractors, vacuum control systems).
Product overview
CAIR LGL is a French medical device manufacturer with over 30 years of experience developing, designing, and manufacturing single-use sterile medical devices. The company's product portfolio is organized into four main therapeutic areas: (1) Infusion solutions featuring the proprietary Neutraclear™ bidirectional needleless injection valve system, Spyder multi-way extension lines, stopcocks, manifolds, Dosicair flow regulators, and various extension lines; (2) Chemotherapy (CHEMO-CAIR) products including dose preparation, bag preparation, administration sets, and Y-sets; (3) Nutrition products under the Nutricair™ Enteral brand with ENFit™ connectors, encompassing feeding tubes, syringes, accessories, and hydration tubing; and (4) Suction-Ventilation equipment including suction tubing, vacuum control systems, mucus extractors, and ventilation devices. The company also offers operating room/patient reconstruction products such as surgical coverings and warming equipment. CAIR LGL operates production facilities in France (Lissieu and Saint Laurent de Chamousset) and Tunisia, with subsidiaries in Belgium, Spain, and Italy.
Differentiator
Problem solved
Functional benefit
Brands
- Neutraclear™: Bidirectional needleless injection valve - a transparent closed system that guarantees neutrality of movement and prevention of infectious risks
- CHEMO-CAIR
- NUTRICAIR™ Enteral
- Dosicair
- SPYDER
Products and services
- Neutraclear™ Bidirectional Needleless Injection Valve
Companies that use CAIR LGL
Customer profileSegments4 records
Ideal customer profiles4 records
CAIR LGL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CAIR LGL partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- French HealthcareminorCAIR LGL is a member of French Healthcare, a national initiative supporting French healthcare companies in their international development.
- SNITEM (Syndicat National de l'Industrie des Technologies Médicales)minorCAIR LGL is a member of SNITEM, the French medical technologies industry association representing medical device manufacturers in France.
- IGL GroupminorCAIR LGL shows IGL Group as a partner on their presentation materials, suggesting a collaborative relationship in the healthcare sector.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
CAIR LGL competitors and assessment
Company assessmentDirect peers
- Vygon: Vygon is a French-headquartered, family-owned manufacturer of single-use medical devices for infusion, neonatology, and enteral nutrition—directly mirroring CAIR LGL's four-vertical portfolio, geography, and SME scale. As one of CAIR LGL's closest like-for-like competitors in French and European hospital accounts, it is the most comparable direct peer.
- ICU Medical: ICU Medical (which acquired Smiths Medical) is a US-listed pure-play in IV therapy, needle-free connectors, and chemotherapy administration sets, giving it a near-identical product focus to CAIR LGL. As a focused infusion/consumables operator, it is more closely comparable than the diversified majors above.
- Polyflex (Bıçakcılar / Euromedis): Euromedis (France) and Bıçakcılar (Turkey) are European-based manufacturers of single-use sterile medical devices for infusion, suction, and urology, frequently competing in the same regional hospital tenders as CAIR LGL. They are direct SME-scale peers with parallel vertical mixes.
Broad incumbents
- B. Braun: B. Braun is a German-headquartered global medical device major with the leading IV infusion set, needle-free connector, and clinical nutrition portfolios (Infusomat/Space, Sterifill, ENFit-compatible devices). It competes head-to-head with CAIR LGL across infusion and nutrition but operates at substantially larger scale and broader geographic reach.
- Fresenius Kabi: Fresenius Kabi is a German-based global leader in clinical nutrition, IV infusion sets, infusion pumps, and single-use disposables, with a comparable vertical mix to CAIR LGL (infusion, parenteral/oral nutrition, oncology admixture). It is a broad incumbent peer against which CAIR LGL positions its Neutraclear and NUTRICAIR lines.
- Baxter International: Baxter is a US-based medical products major with a deep IV sets, IV solutions, and drug delivery portfolio (Viaflo, Mini-Bag, Clearlink needle-free connectors). It is a broad incumbent peer competing with CAIR LGL on infusion consumables in European hospital tenders.
- Becton Dickinson (BD Medical): BD Medical is a global medical-device incumbent with the BD Nexiva, BD Q-Syte, and BD PosiFlush needle-free/IV consumable lines that directly overlap with CAIR LGL's Neutraclear valve and infusion sets. Its scale, US hospital contracts, and innovation pipeline make it a key benchmark broad incumbent peer.
Regional players
- Primed Medical: Primed Medical is a Turkey-based manufacturer of single-use sterile medical devices (IV sets, syringes, surgical disposables) that frequently supplies European and EMEA hospital tenders, making it a regional Mediterranean comparator to CAIR LGL's France–Tunisia manufacturing axis.
Emerging players
- Sentron Medical: Sentron Medical is a niche European SME focused on flow regulators, infusion rate devices, and IV consumables, overlapping with CAIR LGL's DOSICAIR and infusion product categories. As a smaller specialty player, it represents an emerging-style direct peer.
Others
- STERIS (laboratory and sterilization services): While not a direct manufacturer of CAIR LGL's products, STERIS is a global leader in ethylene oxide sterilization and infection prevention, adjacent to CAIR LGL's ISO 11135-certified in-house sterilization operations. It is an ecosystem/peer comparator relevant to its sterilization backbone.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
CAIR LGL social profiles
Digital presenceCAIR LGL compliance and trust
Trust signalCompliance4 records
CAIR LGL financial estimates
Financial estimateRevenue estimate
Valuation estimate
CAIR LGL leadership team
Management profileNumber of profiles
Profiles3 records
CAIR LGL subsidiaries and ownership
Company hierarchySubsidiaries3 records
CAIR LGL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CAIR LGL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CAIR LGL
What does CAIR LGL do?
CAIR LGL designs, develops, manufactures, sterilizes, and distributes single-use sterile medical devices for hospitals and healthcare facilities. Its portfolio spans four therapeutic areas: infusion (needleless valves, extension lines, flow regulators, stopcocks), chemotherapy (CHEMO-CAIR dose preparation, bag preparation, and administration sets), nutrition (NUTRICAIR enteral feeding with ENFit connectors), and suction-ventilation (gastric suction probes, mucus extractors, vacuum control systems).
Is CAIR LGL a public or private company?
CAIR LGL is a private company. It is classified as family owned and is currently operating.
When was CAIR LGL founded?
CAIR LGL was founded in 1987. It employs 251 to 500 people.
Where is CAIR LGL based?
CAIR LGL is headquartered in Lissieu, France, in the Europe region.
How does CAIR LGL make money?
One revenue line is on record: single-use sterile medical device sales.
Who are CAIR LGL's main competitors?
Direct peers on record are Vygon, ICU Medical and Polyflex (Bıçakcılar / Euromedis). Broad incumbents are B. Braun, Fresenius Kabi, Baxter International and Becton Dickinson (BD Medical). Primed Medical is listed as a regional player. Sentron Medical is listed as an emerging player. STERIS (laboratory and sterilization services) is listed as an others.
Does CAIR LGL have an API?
No public API is recorded for CAIR LGL.
What industry is CAIR LGL in?
CAIR LGL's product category is Medical Devices. Its primary akta.pro industry code is HLAHAIAH, Infusion Sets, Catheters & Pump Consumables, with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339113 and its SIC code is 3841.